ERBB2 and cancer: In a recent study, researchers transfected cells to produce EVs with high affinity anti-HER2 antibodies to target the HER2 receptors in HER2 overexpressing cancer cells and demonstrated a greater uptake of EVs expressing antibodies compared to EVs not expressing antibodies 116.